JP2016520050A - 老化筋肉再生の増強方法 - Google Patents

老化筋肉再生の増強方法 Download PDF

Info

Publication number
JP2016520050A
JP2016520050A JP2016512033A JP2016512033A JP2016520050A JP 2016520050 A JP2016520050 A JP 2016520050A JP 2016512033 A JP2016512033 A JP 2016512033A JP 2016512033 A JP2016512033 A JP 2016512033A JP 2016520050 A JP2016520050 A JP 2016520050A
Authority
JP
Japan
Prior art keywords
nutritional composition
muscle
egcg
exemplary embodiments
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016512033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520050A5 (enExample
Inventor
ガーベイ，シーン
ペレイラ，サゼット
エデンス，ネイル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2016520050A publication Critical patent/JP2016520050A/ja
Publication of JP2016520050A5 publication Critical patent/JP2016520050A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016512033A 2013-05-01 2014-05-01 老化筋肉再生の増強方法 Pending JP2016520050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361818237P 2013-05-01 2013-05-01
US61/818,237 2013-05-01
PCT/US2014/036297 WO2014179526A1 (en) 2013-05-01 2014-05-01 Methods for enhancing aged muscle regeneration

Publications (2)

Publication Number Publication Date
JP2016520050A true JP2016520050A (ja) 2016-07-11
JP2016520050A5 JP2016520050A5 (enExample) 2017-06-01

Family

ID=50885012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016512033A Pending JP2016520050A (ja) 2013-05-01 2014-05-01 老化筋肉再生の増強方法

Country Status (11)

Country Link
US (1) US20160066610A1 (enExample)
EP (1) EP2999359A1 (enExample)
JP (1) JP2016520050A (enExample)
CN (1) CN105188413A (enExample)
BR (1) BR112015027563A2 (enExample)
CA (1) CA2911471A1 (enExample)
HK (1) HK1221609A1 (enExample)
MX (1) MX2015015178A (enExample)
PH (1) PH12015502319A1 (enExample)
SG (1) SG11201508388YA (enExample)
WO (1) WO2014179526A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019531748A (ja) * 2016-10-21 2019-11-07 メタボリック・テクノロジーズ，インコーポレーテッド β−ヒドロキシ−β−メチルブチレート（ＨＭＢ）およびプロバイオティックを使用する組成物および方法
JP2021512918A (ja) * 2018-02-09 2021-05-20 ハルドール・トプサー・アクチエゼルスカベット α−ヒドロキシ化合物の製造方法およびその使用
JPWO2023190293A1 (enExample) * 2022-03-30 2023-10-05
US11992041B2 (en) 2017-06-09 2024-05-28 Philip Morris Products S.A. Aerosol-generating article having fibrous filter segment and hollow, tubular support element located immediately downstream the aerosol-forming substrate
US12370159B2 (en) 2016-10-21 2025-07-29 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015094772A1 (en) * 2013-12-18 2015-06-25 Abbott Laboratories Methods for increasing skeletal muscle protein synthesis using green tea extract
WO2016044272A1 (en) * 2014-09-16 2016-03-24 Abbott Laboratories Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract
JP6664956B2 (ja) * 2015-02-27 2020-03-13 キリンホールディングス株式会社 筋分化促進組成物
US10596138B2 (en) 2015-09-16 2020-03-24 Abbott Laboratories Reduced fat, shelf stable liquid nutritional composition
WO2017123922A1 (en) * 2016-01-13 2017-07-20 Metabolic Technologies, Inc. COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR JOINT STABILITY
ES2811378T3 (es) * 2016-04-01 2021-03-11 Dsm Ip Assets Bv Bebidas que comprenden gránulos estables de luteína molida
MX2018014407A (es) 2016-05-25 2019-02-21 Tsi Group Ltd Estabilizacion de formulaciones de acido beta-hidroxiisovalerico en capsulas de gel blando.
US20210368843A1 (en) * 2016-08-04 2021-12-02 Seattle Gummy Company Mineral compositions and methods of making and using thereof
CN109661180A (zh) * 2016-08-04 2019-04-19 西雅图咖米公司 用于运动成绩的组合物及其制造和使用方法
WO2018027081A1 (en) * 2016-08-04 2018-02-08 Seattle Gummy Company Health management compositions and methods of making and using thereof
US20190037904A1 (en) * 2017-08-04 2019-02-07 Sean R. Daly Food-based protein formulation
CN112312772A (zh) * 2018-06-23 2021-02-02 西雅图咖米公司 用于降低咖啡因副作用的方法和组合物
JP6541047B1 (ja) * 2018-10-18 2019-07-10 株式会社東洋新薬 経口組成物
CA3175049A1 (en) * 2020-03-10 2021-04-15 The Regents Of The University Of California Novel nutrients to enhance load-induced muscle hypertrophy
WO2021236440A1 (en) 2020-05-20 2021-11-25 Advanced Food Concepts, Inc. Athletic performance enhancement composition using menthol
CN112568444A (zh) * 2020-11-20 2021-03-30 格乐瑞(无锡)营养科技有限公司 一种缓解肌肉流失的组合物及其制备方法
WO2025030001A2 (en) * 2023-08-02 2025-02-06 Abbott Laboratories Methods and compositions for maintaining skeletal muscle mobility and/or mass, and/or for recovery of skeletal muscle strength

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008063321A (ja) * 2006-08-10 2008-03-21 Kao Corp 筋肉老化抑制剤
JP2009517473A (ja) * 2005-11-30 2009-04-30 ネステク ソシエテ アノニム 筋肉損失の治療のための方法
WO2012092035A1 (en) * 2010-12-27 2012-07-05 Abbott Laboratories Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
WO2007116962A1 (ja) * 2006-04-07 2007-10-18 Osaka University 筋再生促進剤
EP3231435A1 (en) * 2009-07-20 2017-10-18 Nestec S.A. Methods of attenuating the loss of functional status
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
WO2012097064A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009517473A (ja) * 2005-11-30 2009-04-30 ネステク ソシエテ アノニム 筋肉損失の治療のための方法
JP2008063321A (ja) * 2006-08-10 2008-03-21 Kao Corp 筋肉老化抑制剤
WO2012092035A1 (en) * 2010-12-27 2012-07-05 Abbott Laboratories Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019531748A (ja) * 2016-10-21 2019-11-07 メタボリック・テクノロジーズ，インコーポレーテッド β−ヒドロキシ−β−メチルブチレート（ＨＭＢ）およびプロバイオティックを使用する組成物および方法
JP7583523B2 (ja) 2016-10-21 2024-11-14 メタボリック・テクノロジーズ，インコーポレーテッド β－ヒドロキシ－β－メチルブチレート（ＨＭＢ）およびプロバイオティックを使用する組成物および方法
US12370159B2 (en) 2016-10-21 2025-07-29 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics
US11992041B2 (en) 2017-06-09 2024-05-28 Philip Morris Products S.A. Aerosol-generating article having fibrous filter segment and hollow, tubular support element located immediately downstream the aerosol-forming substrate
JP2021512918A (ja) * 2018-02-09 2021-05-20 ハルドール・トプサー・アクチエゼルスカベット α−ヒドロキシ化合物の製造方法およびその使用
JP7368364B2 (ja) 2018-02-09 2023-10-24 トプソー・アクチエゼルスカベット α－ヒドロキシ化合物の製造方法およびその使用
US11882852B2 (en) 2018-02-09 2024-01-30 Haldor Topsøe A/S Process of producing alpha-hydroxy compounds and uses thereof
JPWO2023190293A1 (enExample) * 2022-03-30 2023-10-05

Also Published As

Publication number Publication date
EP2999359A1 (en) 2016-03-30
MX2015015178A (es) 2016-02-26
CN105188413A (zh) 2015-12-23
PH12015502319A1 (en) 2016-02-10
CA2911471A1 (en) 2014-11-06
SG11201508388YA (en) 2015-11-27
HK1221609A1 (zh) 2017-06-09
US20160066610A1 (en) 2016-03-10
BR112015027563A2 (pt) 2017-07-25
WO2014179526A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
JP2016520050A (ja) 老化筋肉再生の増強方法
US9844531B2 (en) Methods of maintaining and improving muscle function
EP2903458B1 (en) Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
US20160361291A1 (en) Methods for increasing skeletal muscle protein synthesis using green tea extract
CA2903561C (en) Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein
PT2590521T (pt) Composição nutricional para a estimulação da síntese de proteínas musculares
US20210220301A1 (en) Pharmaceutical or Nutritional Combination Comprising Beta-Hydroxy-Betamethylbutyrate
WO2013148685A1 (en) Pea protein containing nutritional compositions
JP2016520664A (ja) 粘弾性を付与する分子を含む凝集性液状ボーラス
WO2014099904A1 (en) Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
WO2015094767A1 (en) Methods for maintaining or increasing bodyweight using decaffeinated green tea extract
US20150057346A1 (en) Methods of maintaining intramuscular myoglobin levels, maintaining maximal aerobic capacity, and enhancing the oxidative capacity of muscle in a subject
WO2016044272A1 (en) Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract
JP2025517146A (ja) 軟骨変性における使用のための、フィセチン及びケルセチンの組み合わせを使用した組成物及び方法
WO2015095725A1 (en) Methods and compositions for attenuating muscle protein degradation and preserving lean body mass
AU2019305075A1 (en) Nutritional compositions for enhancement of muscle performance
HK1212560B (en) Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
TW201244642A (en) Methods for improving bone health in infants using prebiotics

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20160202

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20160216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170411

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170411

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180830

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190226